ASP-1929 Photoimmunotherapy Combined With Pembrolizumab in Patients With Recurrent Head and Neck Cancer, With or Without Metastases
Clinical trial NCT05265013 · TERMINATED
Trial details
- NCT number
- NCT05265013
- Sponsor
- Rakuten Medical, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-19
- Primary completion
- 2023-11-20
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.